Overview of therapeutic drug research for COVID-19 in China
Crossref DOI link:
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
Text and Data Mining valid from 2020-06-17
Version of Record valid from 2020-06-17
17 March 2020
10 May 2020
17 June 2020
The authors declare no competing interests.
Free to read:
This content has been made available to all.